Bilfinger Berger notches win in Belgium

May 25, 2011

May 25, 2011

Bilfinger Berger notches win in Belgium

Bilfinger Berger has won a major order in the Belgian biotechnology sector. In Geel, the Company will install a biotechnological production facility for Genzyme, part of the Sanofi pharmaceutical group. The order has a volume of approximately €30 million. With the new order, Bilfinger Berger Industrial Services continues its growth in the pharmaceutical and biotechnology industries.

The core element of the new facility is two production lines, each with a 4,000-litre bioreactor for the production of medication for an enzyme deficiency disease. Bilfinger Berger is responsible for the apparatus assembly and the piping systems. Completion is scheduled for fall 2012.

Bilfinger Berger Industrial Services is an important partner to the pharmaceutical industry and has a significant number of references from well-known clients in the design, construction and maintenance of production facilities. With its broad range of services, the Company has been active for many years at pharmaceutical centres in Germany, France, Austria and Switzerland.